<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27935" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Calcium Pyrophosphate Deposition Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zamora</surname>
            <given-names>Edgar A.</given-names>
          </name>
          <aff>Montefiore Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Naik</surname>
            <given-names>Roopa</given-names>
          </name>
          <aff>Centra Southside Community Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Edgar Zamora declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Roopa Naik declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27935.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Calcium pyrophosphate deposition disease (CPPD) is a crystal deposition arthropathy involving the synovial and periarticular tissues. Its clinical presentation may range from being asymptomatic to acute or chronic inflammatory arthritis. Chronic CPP deposition arthritis informally referred to as pseudo-rheumatoid arthritis may present with a waxing and waning clinical course that may last for several months and resemble rheumatoid arthritis involving the wrists and metacarpophalangeal (MCP) joints. The crystals involved in calcium pyrophosphate deposition disease are composed of calcium pyrophosphate dihydrate and commonly affect larger and weight-bearing joints, including the hips, knees, or shoulders. This activity reviews the etiology, presentation, evaluation, and management of calcium pyrophosphate deposition disease, and reviews the role of the interprofessional team in evaluating, diagnosing, and managing the condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of calcium pyrophosphate deposition disease.</p></list-item><list-item><p>Summarize the diagnostic approach for a patient presenting with potential calcium pyrophosphate deposition disease.</p></list-item><list-item><p>Review the therapeutic options available for the management and treatment of calcium pyrophosphate deposition disease.</p></list-item><list-item><p>Explain interprofessional team strategies for improving care coordination and communication regarding the management of patients with calcium pyrophosphate deposition disease.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27935&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27935">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27935.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Calcium pyrophosphate deposition disease (CPPD) is a crystal deposition arthropathy involving the synovial and periarticular tissues.<xref ref-type="bibr" rid="article-27935.r1">[1]</xref> Its clinical presentation may range from being asymptomatic to acute or chronic inflammatory arthritis.<xref ref-type="bibr" rid="article-27935.r2">[2]</xref></p>
        <p>Different terms are used to describe the varied phenotypes of calcium pyrophosphate deposition disease.<xref ref-type="bibr" rid="article-27935.r1">[1]</xref> Acute calcium pyrophosphate (CPP) deposition arthritis, frequently referred to as &#x0201c;pseudogout,&#x0201d; presents as an acute flare of synovitis that resembles acute urate arthropathy (gout). Chronic CPP deposition arthritis informally referred to as pseudo-rheumatoid arthritis may present with a waxing and waning clinical course that may last for several months and resemble rheumatoid arthritis involving the wrists and metacarpophalangeal (MCP) joints.<xref ref-type="bibr" rid="article-27935.r1">[1]</xref> The term chondrocalcinosis describes the characteristic radiological finding of intraarticular fibrocartilage calcification.<xref ref-type="bibr" rid="article-27935.r3">[3]</xref></p>
        <p>The crystals involved in calcium pyrophosphate deposition disease are composed of calcium pyrophosphate dihydrate and commonly affect larger and weight-bearing joints, including the hips, knees, or shoulders.<xref ref-type="bibr" rid="article-27935.r2">[2]</xref> A large number of patients present with underlying joint disease or metabolic abnormalities predisposing to CPP deposition, including osteoarthritis, trauma, surgery, or rheumatoid arthritis.<xref ref-type="bibr" rid="article-27935.r3">[3]</xref></p>
      </sec>
      <sec id="article-27935.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Calcium pyrophosphate deposition disease is believed to be caused by an imbalance between the production of pyrophosphate and the levels of pyrophosphatases in diseased cartilage. As pyrophosphate deposits in the synovium and adjacent tissues, it combines with calcium to form CPP.<xref ref-type="bibr" rid="article-27935.r4">[4]</xref></p>
        <p>Several comorbidities have correlations with CPPD. In a number of studies, hyperparathyroidism presented the highest positive association with CPPD, followed by gout, osteoarthritis, rheumatoid arthritis, and hemochromatosis. Other comorbidities associated with it include osteoporosis, hypomagnesemia, chronic kidney disease, and calcium supplementation.<xref ref-type="bibr" rid="article-27935.r5">[5]</xref><xref ref-type="bibr" rid="article-27935.r6">[6]</xref><xref ref-type="bibr" rid="article-27935.r7">[7]</xref><xref ref-type="bibr" rid="article-27935.r8">[8]</xref></p>
        <p>Deposition of calcium pyrophosphate is believed to cause activation of the immune system producing inflammation and further soft tissue injury.<xref ref-type="bibr" rid="article-27935.r9">[9]</xref></p>
      </sec>
      <sec id="article-27935.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Most patients affected by acute calcium pyrophosphate deposition arthritis are over the age of 65. Thirty to fifty percent of patients present over the age of 85 years.<xref ref-type="bibr" rid="article-27935.r4">[4]</xref> A cross-sectional study involving 2,157 cases of CPPD in US veterans reported a point prevalence of 5.2 per 1000, with an average age of 68 years and 95% of male prevalence.<xref ref-type="bibr" rid="article-27935.r5">[5]</xref>&#x000a0;CPPD rarely presents in patients under the age of 60.<xref ref-type="bibr" rid="article-27935.r10">[10]</xref></p>
        <p>A large cross-sectional study reported a 4 % crude prevalence of radiographic chondrocalcinosis in the general population.<xref ref-type="bibr" rid="article-27935.r10">[10]</xref></p>
      </sec>
      <sec id="article-27935.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>In patients presenting with acute calcium pyrophosphate arthritis, manifestations are similar to acute urate arthropathy with joint edema, erythema, and tenderness.<xref ref-type="bibr" rid="article-27935.r3">[3]</xref> Up to 50% of these patients may also present with a low-grade fever.<xref ref-type="bibr" rid="article-27935.r1">[1]</xref> The most commonly affected joint is the knee, but other weight-bearing joints may also be affected, including the hips and shoulders.<xref ref-type="bibr" rid="article-27935.r11">[11]</xref></p>
        <p>A subset of patients present with chronic CPP arthritis, often with waxing and waning episodes of non-synchronous, inflammatory arthritis affecting multiple non-weight bearing joints such as wrists and MCP joints, resembling rheumatoid arthritis.<xref ref-type="bibr" rid="article-27935.r1">[1]</xref></p>
        <p>Clinicians should suspect crystal deposition disease in elderly patients presenting with acute degenerative arthritis in weight-bearing joints.<xref ref-type="bibr" rid="article-27935.r9">[9]</xref> The elderly population will commonly run a milder course.<xref ref-type="bibr" rid="article-27935.r12">[12]</xref> Some patients will present acute flares after traumatic injuries.<xref ref-type="bibr" rid="article-27935.r4">[4]</xref></p>
      </sec>
      <sec id="article-27935.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>After an appropriate physical examination, patients suspected to have calcium pyrophosphate deposition disease should undergo arthrocentesis for synovial fluid analysis, in addition to radiography of the involved joints.<xref ref-type="bibr" rid="article-27935.r13">[13]</xref></p>
        <p>Diagnostic confirmation may be via the presence of rhomboid crystals in the synovial fluid aspirate visualized under polarized microscopy. These crystals typically present positive birefringence.<xref ref-type="bibr" rid="article-27935.r4">[4]</xref></p>
        <p>While imaging findings consistent with chondrocalcinosis support the diagnosis of CPPD, its absence does not rule it out.<xref ref-type="bibr" rid="article-27935.r14">[14]</xref> Early signs may be evidenced through ultrasound (US) as cartilage abnormalities. Joint cartilage calcification, known as chondrocalcinosis, may be visualized through radiographic imaging.<xref ref-type="bibr" rid="article-27935.r9">[9]</xref><xref ref-type="bibr" rid="article-27935.r14">[14]</xref><xref ref-type="bibr" rid="article-27935.r15">[15]</xref></p>
        <p>Previous studies have demonstrated the usefulness of magnetic resonance imaging (MRI), particularly gradient-echo sequences, for the evaluation of calcium pyrophosphate crystal deposition burden in joint cartilage.<xref ref-type="bibr" rid="article-27935.r16">[16]</xref></p>
      </sec>
      <sec id="article-27935.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment for patients with calcium pyrophosphate deposition disease is based on decreasing inflammation and stabilizing any underlying metabolic disease that may predispose them to calcium pyrophosphate crystal deposition. In patients with acute flares, with the involvement of one or two joints, the treatment of choice is usually joint aspiration and intra-articular glucocorticoid administration, unless contraindicated.<xref ref-type="bibr" rid="article-27935.r4">[4]</xref><xref ref-type="bibr" rid="article-27935.r17">[17]</xref></p>
        <p>For patients presenting with acute inflammation involving three or more joints, the treatment is typically systemic, often with nonsteroidal anti-inflammatory drugs (NSAIDs). Patients with contraindications for NSAIDs may receive treatment with colchicine or systemic glucocorticoids.<xref ref-type="bibr" rid="article-27935.r1">[1]</xref></p>
        <p>Corticosteroid injection&#x000a0;should only be performed after septic arthritis has been ruled out or considered unlikely. In patients presenting with signs and symptoms suggestive of septic arthritis, the recommendation is to defer glucocorticoid administration until synovial fluid cultures are negative.<xref ref-type="bibr" rid="article-27935.r1">[1]</xref><xref ref-type="bibr" rid="article-27935.r4">[4]</xref></p>
        <p>Other measures include the application of ice packs and joint rest with restriction of weight-bearing to decrease further inflammation. Patients with recurrent episodes of acute CPP arthritis may receive daily low-dose colchicine.<xref ref-type="bibr" rid="article-27935.r4">[4]</xref></p>
        <p>While several medications decrease serum urate levels and prevent urate crystal formation, there is no current therapy directly targeting CPP crystal deposition. Hence, the treatment of CPPD relies on treating predisposing metabolic diseases, soft tissue inflammation, and symptomatology.<xref ref-type="bibr" rid="article-27935.r9">[9]</xref></p>
      </sec>
      <sec id="article-27935.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>As discussed above, calcium pyrophosphate deposition disease has different phenotypes. Therefore, the differential diagnosis should be based on the clinical presentation and may include gout, rheumatoid arthritis, ankylosing spondylitis, and erosive osteoarthritis.<xref ref-type="bibr" rid="article-27935.r4">[4]</xref></p>
        <p>The intra-articular radiological calcification seen in patients with CPPD is characteristic. In knee x-rays, chondrocalcinosis presents as a thin dense intraarticular opacification that runs parallel and separated from the bone cortex or as a calcifying opacification in the menisci.<xref ref-type="bibr" rid="article-27935.r12">[12]</xref><xref ref-type="bibr" rid="article-27935.r15">[15]</xref></p>
        <p>Diagnosis of CPPD is presumed in patients with symptomatic joint disease who present the characteristic radiological findings of chondrocalcinosis.<xref ref-type="bibr" rid="article-27935.r12">[12]</xref> As discussed, several imaging modalities may present characteristic findings of CPPD, including x-ray, US, or MRI.<xref ref-type="bibr" rid="article-27935.r9">[9]</xref>&#x000a0;When needed, a definite diagnosis is achieved by polarizing light microscopy of synovial fluid, showing the presence of CPP crystals.<xref ref-type="bibr" rid="article-27935.r12">[12]</xref><xref ref-type="bibr" rid="article-27935.r15">[15]</xref></p>
      </sec>
      <sec id="article-27935.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Acute calcium pyrophosphate arthritis is generally self-limited, and the inflammation usually resolves within days to weeks of treatment.<xref ref-type="bibr" rid="article-27935.r1">[1]</xref></p>
        <p>Patients with chronic CPP inflammatory arthritis may present overlapping manifestations with rheumatoid arthritis, such as morning stiffness, localized edema, and decreased range of motion. Some patients also present tenosynovitis with carpal or cubital tunnel syndrome.<xref ref-type="bibr" rid="article-27935.r11">[11]</xref>&#x000a0;Multiple joints are commonly involved, and the episodes of inflammation may present in a nonsynchronous, waxing, and waning clinical course lasting several months.<xref ref-type="bibr" rid="article-27935.r7">[7]</xref><xref ref-type="bibr" rid="article-27935.r8">[8]</xref></p>
        <p>Patients with underlying joint comorbidities, such as osteoarthritis, have an increased risk for acute CPP arthritis. When deposited, CPP crystals activate the immune system, promoting inflammation and fibrocartilage injury.<xref ref-type="bibr" rid="article-27935.r1">[1]</xref></p>
      </sec>
      <sec id="article-27935.s10" sec-type="Complications">
        <title>Complications</title>
        <p>The molecular structure of calcium pyrophosphate has the potential of triggering inflammatory responses.<xref ref-type="bibr" rid="article-27935.r9">[9]</xref> The presence of chondrocalcinosis has associations with the degradation of menisci and synovial tissue.<xref ref-type="bibr" rid="article-27935.r16">[16]</xref></p>
        <p>Rarely, patients may present with palpable nodules or masses that resemble gout tophi after several episodes of acute CPP crystal arthritis. These nodules localize in the periarticular tissue and represent CPP crystal accumulations within the synovium and adjacent soft tissue; they may lead to further degradation of the affected joint.<xref ref-type="bibr" rid="article-27935.r18">[18]</xref></p>
        <p>A subset of patients may present with spinal involvement, occasionally causing clinical manifestations such as spine stiffness and bony ankylosis resembling ankylosing spondylitis. Some individuals may have clinical manifestations similar to diffuse idiopathic skeletal hyperostosis (DISH) with calcification of the posterior longitudinal ligament leading to spinal cord compression symptoms.<xref ref-type="bibr" rid="article-27935.r19">[19]</xref><xref ref-type="bibr" rid="article-27935.r20">[20]</xref></p>
      </sec>
      <sec id="article-27935.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with chondrocalcinosis or previous episodes of acute calcium pyrophosphate arthritis will benefit from knowing that certain conditions carry associations with arthritic flares, including surgical procedures or trauma.<xref ref-type="bibr" rid="article-27935.r4">[4]</xref> Individuals who present at a younger age with CPPD may receive screening for underlying metabolic abnormalities such as hyperparathyroidism or hemochromatosis. Obtaining an adequate family history is also necessary.<xref ref-type="bibr" rid="article-27935.r21">[21]</xref></p>
      </sec>
      <sec id="article-27935.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Chondrocalcinosis is a relatively common imaging finding in asymptomatic patients. Studies have described a higher prevalence of these findings in late adulthood without gender predilection.<xref ref-type="bibr" rid="article-27935.r22">[22]</xref> Furthermore, although chondrocalcinosis correlates with osteoarthritis, studies suggest that the risk of both diseases increases independently with age, meaning that chondrocalcinosis may develop without osteoarthritis.<xref ref-type="bibr" rid="article-27935.r23">[23]</xref> Asymptomatic older patients may not require further workup or therapy for an isolated finding of chondrocalcinosis.</p>
        <p>Due to a broad range of clinical manifestations, calcium pyrophosphate deposition disease should be considered in patients presenting with signs and symptoms suggestive of rheumatoid arthritis or ankylosing spondylitis.<xref ref-type="bibr" rid="article-27935.r24">[24]</xref></p>
        <p>A number of specialists use the high-resolution US in the evaluation of patients with crystal arthropathies, as it may provide useful findings to help differentiate CPPD from other conditions such as gout. Chondrocalcinosis presents earlier in the US than in plain films. This modality may also find use in patients with symptomatic arthropathies of unclear etiology, or with inconclusive results in the fluid aspirate. Additionally, it could potentially decrease the need for using more expensive imaging modalities such as MRI.<xref ref-type="bibr" rid="article-27935.r16">[16]</xref><xref ref-type="bibr" rid="article-27935.r25">[25]</xref><xref ref-type="bibr" rid="article-27935.r26">[26]</xref></p>
      </sec>
      <sec id="article-27935.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27935&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27935">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/joint-muscle-and-bone/calcium-pyrophosphate-deposition-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27935">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27935/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27935">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-27935.s14">
        <fig id="article-27935.image.f1" position="float" orientation="portrait">
          <caption>
            <p>CPP and Urate Crystals Image courtesy of S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CPPurate" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-27935.s15">
        <title>References</title>
        <ref id="article-27935.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosales-Alexander</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Balsalobre Aznar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Magro-Checa</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Calcium pyrophosphate crystal deposition disease: diagnosis and treatment.</article-title>
            <source>Open Access Rheumatol</source>
            <year>2014</year>
            <volume>6</volume>
            <fpage>39</fpage>
            <page-range>39-47</page-range>
            <pub-id pub-id-type="pmid">27790033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bencardino</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Hassankhani</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Calcium pyrophosphate dihydrate crystal deposition disease.</article-title>
            <source>Semin Musculoskelet Radiol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>175</fpage>
            <page-range>175-85</page-range>
            <pub-id pub-id-type="pmid">14593559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abhishek</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Calcium pyrophosphate deposition disease: a review of epidemiologic findings.</article-title>
            <source>Curr Opin Rheumatol</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>133</fpage>
            <page-range>133-9</page-range>
            <pub-id pub-id-type="pmid">26626724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Higgins</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Gout and pseudogout.</article-title>
            <source>JAAPA</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>50</fpage>
            <page-range>50-2</page-range>
            <pub-id pub-id-type="pmid">26914781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kleiber Balderrama</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rosenthal</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Lans</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bartels</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans.</article-title>
            <source>Arthritis Care Res (Hoboken)</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>69</volume>
            <issue>9</issue>
            <fpage>1400</fpage>
            <page-range>1400-1406</page-range>
            <pub-id pub-id-type="pmid">27898996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Galozzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Oliviero</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Frallonardo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Favero</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hoxha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scanu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lorenzin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ortolan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Punzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ramonda</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The prevalence of monosodium urate and calcium pyrophosphate crystals in synovial fluid from wrist and finger joints.</article-title>
            <source>Rheumatol Int</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>443</fpage>
            <page-range>443-6</page-range>
            <pub-id pub-id-type="pmid">26440935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerster</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Varisco</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Kern</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dudler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>So</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>CPPD crystal deposition disease in patients with rheumatoid arthritis.</article-title>
            <source>Clin Rheumatol</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>468</fpage>
            <page-range>468-9</page-range>
            <pub-id pub-id-type="pmid">16365684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Theiler</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Quehenberger</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rainer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Neubauer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stettin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Robier</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The detection of calcium pyrophosphate crystals in the synovial fluid of patients with rheumatoid arthritis using the cytospin technique: prevalence and clinical correlation.</article-title>
            <source>Rheumatol Int</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>137</fpage>
            <page-range>137-9</page-range>
            <pub-id pub-id-type="pmid">23269567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tausche</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Aringer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Chondrocalcinosis due to calcium pyrophosphate deposition (CPPD). From incidental radiographic findings to CPPD crystal arthritis].</article-title>
            <source>Z Rheumatol</source>
            <year>2014</year>
            <month>May</month>
            <volume>73</volume>
            <issue>4</issue>
            <fpage>349</fpage>
            <page-range>349-57; quiz 358-9</page-range>
            <pub-id pub-id-type="pmid">24811359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neame</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Muir</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Doherty</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>62</volume>
            <issue>6</issue>
            <fpage>513</fpage>
            <page-range>513-8</page-range>
            <pub-id pub-id-type="pmid">12759286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamamura</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Acute CPP Crystal Arthritis Causing Carpal Tunnel Syndrome.</article-title>
            <source>Intern Med</source>
            <year>2018</year>
            <month>Oct</month>
            <day>01</day>
            <volume>57</volume>
            <issue>19</issue>
            <fpage>2767</fpage>
            <page-range>2767-2768</page-range>
            <pub-id pub-id-type="pmid">29780133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MUNDAY</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>PSEUDOGOUT.</article-title>
            <source>Br Med J</source>
            <year>1964</year>
            <month>Oct</month>
            <day>10</day>
            <volume>2</volume>
            <issue>5414</issue>
            <fpage>889</fpage>
            <page-range>889-90</page-range>
            <pub-id pub-id-type="pmid">14185646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Daily</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Pohlgeers</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Acute Monoarthritis: Diagnosis in Adults.</article-title>
            <source>Am Fam Physician</source>
            <year>2016</year>
            <month>Nov</month>
            <day>15</day>
            <volume>94</volume>
            <issue>10</issue>
            <fpage>810</fpage>
            <page-range>810-816</page-range>
            <pub-id pub-id-type="pmid">27929277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Doherty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bardin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Barskova</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Guerne</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Leeb</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Perez-Ruiz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pimentao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Punzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Richette</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sivera</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Uhlig</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Watt</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pascual</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>563</fpage>
            <page-range>563-70</page-range>
            <pub-id pub-id-type="pmid">21216817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schlee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bollheimer</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Bertsch</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sieber</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>H&#x000e4;rle</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Crystal arthritides - gout and calcium pyrophosphate arthritis : Part&#x000a0;2: clinical features, diagnosis and differential diagnostics.</article-title>
            <source>Z Gerontol Geriatr</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>579</fpage>
            <page-range>579-584</page-range>
            <pub-id pub-id-type="pmid">28233118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gersing</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Schwaiger</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Heilmeier</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Facchetti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kretzschmar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>McCulloch</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Nevitt</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Steinbach</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Link</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of Chondrocalcinosis and Associated Knee Joint Degeneration Using MR Imaging: Data from the Osteoarthritis Initiative.</article-title>
            <source>Eur Radiol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>2497</fpage>
            <page-range>2497-2506</page-range>
            <pub-id pub-id-type="pmid">27704199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sidari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Treatment of Gout and Pseudogout for Everyday Practice.</article-title>
            <source>Prim Care</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-236</page-range>
            <pub-id pub-id-type="pmid">29759121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kuang</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A Case of Tophaceous Pseudogout on 18F-FDG PET/CT Imaging.</article-title>
            <source>Clin Nucl Med</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>e98</fpage>
            <page-range>e98-e100</page-range>
            <pub-id pub-id-type="pmid">30325826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muthukumar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Karuppaswamy</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Tumoral calcium pyrophosphate dihydrate deposition disease of the ligamentum flavum.</article-title>
            <source>Neurosurgery</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>53</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-8; discussion 108-9</page-range>
            <pub-id pub-id-type="pmid">12823879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yayama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Uchida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kokubo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakajima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takamura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mwaka</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Orwotho</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Baba</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Calcium pyrophosphate crystal deposition in the ligamentum flavum of degenerated lumbar spine: histopathological and immunohistological findings.</article-title>
            <source>Clin Rheumatol</source>
            <year>2008</year>
            <month>May</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>597</fpage>
            <page-range>597-604</page-range>
            <pub-id pub-id-type="pmid">17934688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abhishek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Doherty</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Update on calcium pyrophosphate deposition.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2016</year>
            <season>Jul-Aug</season>
            <volume>34</volume>
            <issue>4 Suppl 98</issue>
            <fpage>32</fpage>
            <page-range>32-8</page-range>
            <pub-id pub-id-type="pmid">27586801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stensby</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lawrence</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Patrie</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Gaskin</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of asymptomatic chondrocalcinosis in the pelvis.</article-title>
            <source>Skeletal Radiol</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>45</volume>
            <issue>7</issue>
            <fpage>949</fpage>
            <page-range>949-54</page-range>
            <pub-id pub-id-type="pmid">27037810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Felson</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Naimark</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kannel</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Meenan</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study.</article-title>
            <source>J Rheumatol</source>
            <year>1989</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>9</issue>
            <fpage>1241</fpage>
            <page-range>1241-5</page-range>
            <pub-id pub-id-type="pmid">2810282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moshrif</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laredo</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Bassiouni</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Abdelkareem</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Richette</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rigon</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Bardin</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Spinal involvement with calcium pyrophosphate deposition disease in an academic rheumatology center: A series of 37 patients.</article-title>
            <source>Semin Arthritis Rheum</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>48</volume>
            <issue>6</issue>
            <fpage>1113</fpage>
            <page-range>1113-1126</page-range>
            <pub-id pub-id-type="pmid">30415946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grassi</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Okano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Filippucci</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Use of ultrasound for diagnosis and monitoring of outcomes in crystal arthropathies.</article-title>
            <source>Curr Opin Rheumatol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>147</fpage>
            <page-range>147-55</page-range>
            <pub-id pub-id-type="pmid">25633243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27935.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Filippucci</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Di Geso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Girolimetti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Grassi</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound in crystal-related arthritis.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2014</year>
            <season>Jan-Feb</season>
            <volume>32</volume>
            <issue>1 Suppl 80</issue>
            <fpage>S42</fpage>
            <page-range>S42-7</page-range>
            <pub-id pub-id-type="pmid">24528621</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
